0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

URETHANE IN LEUKEMIA

Alexander Haddow, M.D.; Edith Paterson, M.B., F.R.C.P.
JAMA. 1948;136(9):643-644. doi:10.1001/jama.1948.02890260051022.
Text Size: A A A
Published online

ABSTRACT

To the Editor:—  According to J. J. Webster (The Journal, Dec. 6, 1947, p. 901) available reports on the subject of urethane in leukemia "are chiefly in the British and German journals, and represent an optimistic view as to the future of urethane therapy." As far as the original paper was concerned (Paterson, E.; Ap Thomas, I.; Haddow, A., and Watkinson, J. M.: Lancet1:677, 1946), it was certainly not our intention to create any impression of optimism, and we do not consider that such could in fact have been conveyed to the majority of readers. While the palliative effects of urethane were recognized as remarkably similar to those obtained by standard methods of high voltage roentgen therapy, it was on the contrary made clear that no indication had been found "that permanent benefit may result from the use of urethane in either myeloid or lymphatic leukaemia." This goes considerably

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();